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INTRODUCTION 
 
Gene expression regulation 
 
Gene expression includes all the events that go from the transcription of a gene to the 
production of the corresponding protein. All these events are finely regulated. Studying 
gene expression means to understand in which tissue a gene is expressed, how it is 
expressed and what causes its expression. In fact, phenotypic differences among 
different cell types are mainly due to differences in gene expression patterns. 
Gene expression can be regulated at different levels: activation of DNA structure, start 
of transcription, maturation of the transcript, transport into the cytoplasm, translation of 
mRNA and protein stability. Nevertheless, the most important step is the start of the 
transcription process which determines whether a gene is transcribed or not. RNA 
polymerase II, as well as RNA polymerase I and III, needs proteins to find the right 
transcription start site and these proteins necessary for the start of the transcription 
process are called general initiation factors. Given that RNA polymerases and general 
initiation factors are the ultimate targets of regulatory events, during the assemblage of 
the RNA polymerases complex there are several points for regulation to take place. It is 
important to note that purified RNA polymerases and corresponding general initiation 
factors have an intrinsic ability to accurately transcribe DNA templates through core 
promoter elements, thus allowing the fundamental transcription mechanisms to be 
elucidated, but these activities are generally suppressed in the cell by the packaging of 
DNA within chromatin and by negative cofactors that directly interfere with the 
function of the basal transcription factors. As discussed below, this imposes 
requirements for transcriptional activators and corresponding cofactors that act in a 
gene-specific manner both to reverse the repression (antirepression) and to effect a net 
activation above the intrinsic activity of the basal transcription machinery. 
It is possible to subdivide transcriptional factors that cooperates directly with RNA 
polymerase II in three different categories: a) general transcription factors; b) upstream 
transcription factors; c) inducible transcriptional factors. 
a) General transcription factors are necessary for the start of RNA synthesis in all the 
genes of class II (genes that encodes for proteins). They form a complex with the RNA 
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polymerase II close to the transcription start site and this complex is called basal 
complex of transcription. 
b) Upstream transcriptional factors are proteins that recognize short consensus sequence 
situated upstream the transcription start site (an example is the Sp1 factor that 
recognizes GC boxes). These factors are ubiquitous and they act increasing the 
transcription efficiency of all the genes containing a GC box in their promoter. 
c) Inducible transcriptional factors work like upstream factors, but they have e 
regulatory role. They are synthesized or activated in a tissue-specific manner and they 
recognize sequences called response elements. 
In general, transcription factors acts directly recognizing specific and well conserved 
cis-sequences situated in promoters or enhancers. Some of these factors and of these 
sequences are common to more than a promoter and they are used in a constitutive 
manner; some other are specific and their activity is finely regulated. During the 
assembly process of these factors onto the regulatory sequences there are a lot of check-
points and the speed of transcription can be increased or decreased in response to 
different regulatory signals. Nevertheless, not all the transcription factors bind these 
specific sequences on the promoter, they can also recognize other proteins already 
bound to the promoter, and sometimes they can bind directly to the RNA polymerase. 
Often DNA-binding factors that regulate the transcription of protein-coding genes act 
together with an expanding group of cofactors that act either through modifications of 
the chromatin structure or, more directly, regulating formation or function (transcription 
initiation or elongation) of the pre-initiation complex. Requirement for cofactors 
involved more directly in transcription is somewhat surprising in view of the specificity 
intrinsic to the various DNA-binding regulatory factors, the structural complexity of 
their ultimate target (the basal transcription machinery), and documented interactions 
between regulatory factors and components of the basal transcription machinery. Early 
studies of activator functions in systems reconstituted with DNA templates and purified 
RNA polymerase II and corresponding general initiation factors revealed that additional 
‘‘coactivator’’ or ‘‘mediator’’ activities were required for the activator function but not 
for basal (activator-independent) transcription. 
Coactivators functions in a variety of ways and often contain the enzymatic activities 
necessary for an alteration in chromatin structure from a quiescent state to one allowing 
active gene transcription. Broadly speaking, coactivators can be divided in three 
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classes. One class of proteins modifies histones in ways that allow greater access of 
other proteins to the DNA. Examples of these are p300 and CBP, powerful histone 
acetyltransferases (HATs) that interact with a wide variety of transcription factors and 
other proteins (Hermanson et al., 2002). These proteins support transcription in vitro 
from chromatinized templates. A second class of coactivators are members of the 
TRAP/DRIP/Mediator/ARC complex, proteins that bind to transcription factors, recruit 
RNA polymerase II and interact with the general transcription apparatus. The Mediator 
complex supports transcription in vitro from DNA? templates but does not support 
efficient transcription from chromatinized templates.?Lastly, protein complexes of the 
yeast SWI/SNF family (or their mammalian homologs BRG1 or BRM) contain ATP-
dependent DNA unwinding activities, necessary for efficient gene transcription in vivo. 
These groups of proteins will not support transcription from naked DNA, but augment 
transcription from chromatinized templates in vitro (Lemon et al., 2001).  
Co-repressors have the opposite effect on chromatin?structure, making it inaccessible to 
the binding of transcription factors or resistant to their actions. These proteins (such as 
NcoR) are often associated with histone deacetylase (HDAC) activity, though other 
mechanisms for gene silencing clearly exist (Hermanson et al., 2002). Although 
coactivators are defined as proteins that?increase transcriptional activity without binding 
to DNA,? it is useful to think of those that bind directly to transcription factors and 
contain relevant enzymatic activities? as primary coactivators. Those that dock on?
transcription factors and serve as scaffolds for the recruitment of other proteins 
containing these enzymatic activities can be considered secondary co-activators. This 
distinction rapidly blurs as proteins that can function as primary?coactivators on some 
transcription factors can also be? used as enzymatic tools assembled by secondary 
coactivators in other contexts. 
 
 
TAZ 
 
TAZ (Transcriptional co-Activator with PDZ binding motif), also referred to as Wwtr1 
(WW-domain containing transcription regulator 1), is a transcriptional co-activator 
highly expressed in kidney, heart, lung, liver, testis, and placenta. TAZ is characterized 
by a  central WW-domain followed by a highly conserved C-terminal sequence, which 
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contains a coiled-coil domain that recruits core components of the transcriptional 
machinery. Both human and mouse TAZ contain a single WW domain that is a very 
common domain that mediates protein-protein interaction. TAZ also contains a PDZ-
binding motif at its C-terminus, that is required for its transcriptional coactivator 
activity and promotes TAZ nuclear localization particularly to discrete foci, and a      
14-3-3 binding motif within the conserved N-terminal portion. 
 
 
 
 
Domain organization of TAZ: Transcriptional enhanced factors binding domain (TB), 14-3-3 binding domain, WW domain (WW), 
Transcriptional activation domain (TA) and PDZ binding motif. 
 
 
How extracellular cues are transduced to the nucleus is a fundamental issue in biology. 
In this context, TAZ constitutes a transducer linking cytoplasmic signaling events to 
transcriptional regulation in the nucleus and the 14-3-3 binding is the key to this 
regulation.  
Interaction of TAZ and YAP (the paralog of TAZ) with the phosphoserine and 
phosphothreonine-binding proteins 14-3-3 has been known for many years (Kanai et al. 
2000; Vassilev et al 2001; Basu et al. 2003). Hence, an important question is which 
kinases mediate the phosphorylation and link this event to dynamic signaling networks. 
Different groups have recently demonstrated that the fly Hippo pathway and the 
mammalian Hippo-like pathway play a key role in stimulating 14-3-3 interaction with 
the YAP/TAZ family of transcriptional coregulators. 
The fly protein Hippo is a Ste20 protein kinase that interacts with and is activated by 
the WW-domain protein Salvador. Upstream from Hippo are different components, 
including Expanding and Merlyn and an atypical cadherin Fat, which localizes directly 
to the plasma membrane. This component might link Hippo to extracellular cues. 
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Downstream of Hippo are Warts/Lats and its activator Mats. Lats directly interact and 
phosphorilates Yorkie (the fly ortholog of YAP) and this phosphorylation stimulates 
14-3-3 binding to Yorkie and its nuclear export. A series of regulators form a signaling 
cascade to promote 14-3-3 binding and cytoplasmic localization of Yorkie, thereby 
controlling its transcriptional coactivator role. 
As illustrated in the figure below, these signaling regulators are conserved in mammals. 
The mammalian counterparts are FERM domain protein (FERM) 6, neurofibromatosis 
(NF) 2, the Hippo-like kinases MSTs, the regulatory protein WW45, LATS kinases, 
and Mob1. As shown for Yorkie, LATS kinases phosphorylate YAP and TAZ to 
promote their 14-3-3 binding and subsequent nuclear export, thereby placing YAP and 
TAZ downstream from the Hippo-like pathway in mammals. Phosphorylation by LATS 
is multisite, with five sites on YAP and four sites on TAZ. The four sites on TAZ are 
analogous to the C-terminal four sites on YAP and three of the analogous sites are 
conserved in Yorkie but only one is required for 14-3-3 binding, i.e. Ser89, in TAZ. 
 
 
 
 
Comparison between Hippo pathway in fly (Drosophila melanogaster) and mammal.  
 
 
Apart from the Hippo-like pathway, growth factors such as bone morphogenetic protein 
2 (BMP-2) and fibroblast growth factor 2 (FGF-2) regulate TAZ expression and cell 
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differentiation. In addition, through its WW domain, TAZ interacts with polyomavirus 
T antigens and this interaction induces nuclear accumulation of TAZ but inhibits its 
transactivation activity suggesting that nuclear localization of TAZ does not always 
correlate with its transactivation activity, and may thus have other roles. 
TAZ has been defined as a “molecular rheostat” that modulates Mesenchymal stem 
cells (MSCs) differentiation. Two key transcription factors, Runx2 (also called Cbfa1 
or Pebp2aA) and PPARγ, drive MSCs to differentiate into either osteoblasts or 
adipocytes, respectively, and the differentiation of each lineage appears to be mutually 
exclusive and transcriptionally controlled. TAZ interacts both in vitro and in vivo with 
Runx2 and this interaction leads to Runx2-stimulated osteocalcin gene expression. On 
the other hand TAZ interacts both in vitro and in vivo also with PPARγ but, in this 
case, it has been demonstrated that TAZ directly inhibit the ability of PPARγ to 
stimulate gene expression of the endogenous fatty acid-binding protein aP2, both in the 
presence or absence of the PPARγ-activating ligand Rosiglitazone. All together, these 
are evidence suggesting that TAZ acts as a transcriptional modifier of mesenchymal 
stem cell differentiation by promoting osteoblast differentiation while simultaneously 
impairing adipocyte differentiation. 
In the last years, a role of TAZ in the migration, invasion, and tumorigenesis of breast 
cancer cells has been outlined. In fact, the most highly invasive breast cancer cell lines 
express TAZ at levels that are approximately four times of those expressed by the 
majority of the weakly invasive breast cancer cells. The clinical relevance of this 
observation is supported by the finding that TAZ is overexpressed in a significant 
fraction of breast cancers (~21.4% of 126?commercially available breast cancer samples 
examined). Overexpression of TAZ in MCF10A cells (mammary epithelial cells) to a 
level ~2- to 3-fold of those detected in highly invasive cells caused a morphologic 
change from an epithelial to a fibroblast-like appearance an dramatically increased the 
migratory and invasive properties of the cells. Furthermore, shRNA-mediated 
knockdown of TAZ expression in MCF7 (human breast adenocarcinoma cell line ) and 
Hs578T (non-tumorigenic mammary cells able to form colonies in semisolid medium)  
cells reduced cell migration and invasion. The epithelial clusters of MCF7 cells became 
more densely packed with cells when TAZ expression was knocked down. These 
results indicate that TAZ is a negative regulator of epithelial morphology/architecture, 
as well as a positive regulator for invasive and migratory behavior. It is conceivable 
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that TAZ overexpression in breast cancer may trigger the loss of epithelial property to 
promote migration. Moreover, when TAZ expression is knocked down in MCF7 cells, 
their anchorage-independent growth in soft agar and tumorigenesis in nude mice is 
retarded, suggesting that TAZ overexpression is an important part of the process 
involved in breast cancer development and progression. 
Varelas et al. (Nature Cell Biology, 2008) described TAZ like a mediator of Smad 
nucleocytoplasmic shuttling that is essential for TGFβ signaling. In fact, although 
TGFβ-dependent R-Smad phosphorylation and heteromeric complex formation occur in 
the absence of TAZ, nuclear accumulation of Smad complexes is lost. This results in 
loss of TGFβ-dependent signaling, which in hESCs (human Embryonic Stem Cells) 
results in the failure to maintain self-renewal markers. By modulating TAZ localization 
they demonstrated that TAZ dominantly controls the subcellular localization of the 
Smads. They further showed that the Mediator complex component ARC105 binds to 
and can retain TAZ in the nucleus. As TAZ itself shuttles in and out of the nucleus, 
these results support the existence of a hierarchical system that regulates the 
localization of Smad2/3 in the cell. 
To date TAZ knock-out mice have been described in four papers (Hossain et al. 2006; 
Tian et al. 2007; Lei et al. 2008; Mitani et al. 2009). As mentioned before, TAZ was 
reported as a modulator of mesenchimal stem cell differentiation. Despite this,  the 
staining of embryonic day 17.5 (E17.5) TAZ-/- mice embryos with Alcian blue and 
Alizarin red to reveal cartilage and bone tissue respectively, showed only minor skeletal 
abnormalities and knock-out mice present just a slightly smaller stature than wild type. 
Overall, the most relevant phenotypes described in TAZ null mice are severe polycystic 
kidney disease and lung emphysema. Signs of histological anomalies in TAZ-/- kidneys 
were first apparent around E15.5 as dilations of the Bowman’s space between visceral 
podocytes and the parietal cell layer of the Bowman’s capsule. Pathological changes in 
TAZ-/- kidneys included parietal and tubular basement membrane thickening, thinning, 
and folding, and interstitial fibrosis and inflammation as evidenced by mononuclear 
leukocyte infiltration. TAZ-deficient mice have also emphysema-like features including 
enlarged air space and low elastance. These mice exhibit abundant inflammatory cells 
in?bronchoalveolar lavage fluid, evidence of chronic inflammation in lungs, and some 
TAZ-/- lungs have small focal areas with inflammatory changes. Therefore, it looks like 
TAZ plays an important role in lung development, especially during alveolar stages. 
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The Thyroid 
 
The thyroid is one of the largest endocrine gland in the body and is composed of two 
cone-like lobes or wings: lobus dexter (right lobe) and lobus sinister (left lobe); and it is 
also connected with the isthmus. The thyroid gland is an organ situated on the anterior 
side of the neck and its name is due to its shield shape (from the greek tireòs = shield). 
 
 
 
 
 
 
The thyroid gland (pink) is situated on the anterior side of the neck in front of trachea. 
 
 
In a fully differentiated thyroid we can find two cellular types: the follicular cells and 
the parafollicular cells (De Felice and Di Lauro, 2004). 
 
 
 
 
In the thyroid gland are well distinguishable Parafollicular cells and Follicular cells (filled with colloid). 
 
 
The follicular cells produce thyroid hormones T3 and T4 while the parafollicular cells 
produce calcitonin. Thyroid hormones are synthesized into colloids by iodination and 
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condensation of thyroxin molecules bound to thyroglobulin (Tg) by a peptide bond. Tg 
is a glycoprotein that acts both like a substrate for the synthesis of thyroid hormones 
and as a storage of them. Via a reaction with the enzyme thyroperoxidase, iodine is 
covalently bound to tyrosine residues in Tg molecules, forming monoiodotyrosine 
(MIT) and diiodotyrosine (DIT). Thyroxine (T4) is produced by combining two 
molecules of DIT while triiodothyronine (T3) is produced by combining one molecule 
of MIT and one molecule of DIT. 
 
 
 
 
 
 
 
 
 
Mechanism of thyroid gland functioning 
 
 
Most of the thyroid hormones circulating in the blood is bound to transport proteins. 
Only a very small fraction of the circulating hormone is free (unbound) and biologically 
active, hence measuring concentrations of free thyroid hormones is of great diagnostic 
value. When thyroid hormone is bound, it is not active, so the amount of free T3/T4 is 
what really matters. For this reason, measuring total thyroxine in the blood can be 
misleading. T3 bind almost exclusively to Thyroxin Binding Globulin (TBG) while 
80% of T4 bind  to TBG, 15% to Thyroxin Binding Prealbumin (TBPA) and remaining 
5% to seroalbumin. 
It is likely that all the cells in the body are targets for thyroid hormones. While not 
strictly necessary for life, thyroid hormones have profound effects on many 
fundamental physiologic processes, such as development, growth and metabolism. 
Thyroid hormones stimulate diverse metabolic activities in a lot of tissues, leading to an 
increase in basal metabolic rate. One consequence of this activity is to increase body 
heat production, which seems to result, at least in part, from increased oxygen 
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consumption and rates of ATP hydrolysis. Thyroid hormones regulate lipid 
metabolism; in fact, increased thyroid hormone levels stimulate fat mobilization, 
leading to increased concentrations of fatty acids in the plasma. They also enhance 
oxidation of fatty acids in many tissues. Finally, plasma concentrations of cholesterol 
and triglycerides are inversely correlated with thyroid hormone levels - one diagnostic 
indication of hypothyroidism is increased blood cholesterol concentration. Thyroid 
hormone play also a role in the carbohydrate metabolism. They stimulate almost all 
aspects of carbohydrate metabolism, including enhancement of insulin-dependent entry 
of glucose into cells and increased gluconeogenesis and glycogenolysis to generate free 
glucose. 
Thyroid hormones are clearly necessary for normal growth in children and young 
animals, as evidenced by the growth-retardation observed in thyroid deficiency. Not 
surprisingly, the growth-promoting effect of thyroid hormones is intimately intertwined 
with that of growth hormone, a clear indication that complex physiologic processes like 
growth depend upon multiple endocrine controls. Also it is of critical importance in 
mammals the fact that normal levels of thyroid hormone are essential to the 
development of the fetal and neonatal brain.  
Thyroid hormones also acts on the cardiovascular system where they increases heart 
rate, cardiac contractility and cardiac output. They also promote vasodilation, which 
leads to enhanced blood flow to many organs, like for example: a) the central nervous 
system, in which both decreased and increased concentrations of thyroid hormones lead 
to alterations in mental state (too little thyroid hormone, and the individual tends to feel 
mentally sluggish, while too much induces anxiety and nervousness); b) the 
reproductive system in which normal reproductive behavior and physiology is 
dependent on having essentially normal levels of thyroid hormone (hypothyroidism in 
particular is commonly associated with infertility). 
The thyroid gland is under the control of the pituitary gland, a small gland the size of a 
peanut at the base of the brain. When the level of T3 and T4 drops too low, the pituitary 
gland produces Thyroid Stimulating Hormone (TSH) which stimulates the thyroid 
gland to produce more hormones. Under the influence of TSH, the thyroid will 
manufacture and secrete T3 and T4 thereby raising their blood levels. The pituitary 
senses this and responds by decreasing its TSH production. The pituitary gland itself is 
regulated by another gland, known as the hypothalamus (shown in light blue in the 
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picture). The hypothalamus is part of the brain and produces TSH Releasing Hormone 
(TRH) which tells the pituitary gland to stimulate the thyroid gland  by releasing TSH. 
 
 
?
 
A schematic representation of the axis Hypothalamus-Pituitary gland-Thyroid. 
 
 
Thyroid-enriched transcription factors 
 
TTF-1/Titf1, also named T-EBP or Nkx2.1, is a member of the Nkx-2 subfamily, 
originally identified as a protein able to bind to a DNA sequence that is present three 
times on both the Tg and the TPO promoters, and it is involved in the activation of 
thyroid-specific gene expression. TTF-1 is also expressed in the lung, and its presence 
is required for the transcriptional activation of surfactant proteins A, B, and C and Clara 
secretory protein. The critical role of TTF-1 for both thyroid and lung morphogenesis 
was clarified in TTF-1 null mice that resulted not viable and lacked the thyroid, the 
pituitary gland and the lung parenchyma. Deep study revealed that in these mice at the 
begin of the embryogenesis the thyroid primordium forms in its correct position, but 
subsequently, the thyroid precursor cells undergo apoptosis (Kimura et al., 1999) and 
disappear at E10.5–11.5. During mouse development TTF-1 expression starts at day 
E8.5 in endodermal cells that later will become the pharynx and its onset clashes with 
the proliferation of the cells of the endodermal layer. This event is the first step of the 
development of the thyroid. 
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Foxe1 is a member of FOX (Forkhead box) proteins which are a family of transcription 
factors that play important roles in regulating the expression of genes involved in cell 
growth, proliferation, differentiation. FOX proteins are able to bind DNA through the 
forkhead domain that is a domain common among several transcription factors involved 
in development and differentiation. In the mouse, Foxe1 expression starts at 8 dpc into 
the endodermal cells of the pharynx and it is more evident in the posterior area of the 
pharynx, where TTF-1 is not expressed. Hence, this expression pattern suggests that 
Foxe1 has a less important roles during the first steps of development whereas it’s very 
important for the migration of the thyroid gland during embryogenesis. In fact the 
analysis of Foxe1 knock-out mice revealed that thyroid starts to develop normally but, 
at day E10.5, the thyroid primordium fails to migrate towards its correct position in 
front of the trachea attached to pharyngeal endoderm suggesting that Foxe1 might be 
important during the migration of the thyroid during its development, probably 
regulating the expression of genes involved in cellular migration. 
Pax8 is a member of the Pax gene family, a family of genes that encode for DNA-
binding proteins involved in the regulation of the development of a variety of tissues in 
different species. The Pax gene family is composed of nine proteins highly conserved in 
vertebrates and all these proteins are characterized by the presence of the paired box. 
This specific sequence encodes for the paired domain, a very important domain for 
recognizing the target sequences on DNA. The paired domain is composed of 128 
amino acids and is subdivided in two fundamental subdomains, one at C-terminus the 
other at N-terminus, called pai and red, respectively. Each of these domains contain an 
helix-turn-helix motif and both domains are united by a linker region. We can explain 
the subdivision of the paired domain into two independent domains with the ability of 
Pax proteins family to bind DNA in different ways and overall to recognize a lot of 
sequences. Within the omology rate of the paired domains we can subdivide the nine 
Pax proteins in different groups. One of these groups is composed by Pax2, Pax5 and 
Pax8. These three proteins are characterized also by the presence of an octapeptide and 
a partial omeodomain.  
During embryonic development Pax8 is expressed in thyroid, kidney and the nervous 
tissue. Pax8 has been demonstrated to be required both for the morphogenesis of the 
thyroid gland and for the maintenance of the thyroid-differentiated phenotype. In Pax8 
null mouse embryos initial phases of organogenesis are normal but, at E11.5, the 
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thyroid primordium appears much smaller than in wild type embryos and at E12 the 
follicular cells are almost undetectable (Mansouri et al., 1998). Although the relevance 
of the role of Pax proteins is becoming more and more clear, the molecular mechanisms 
of their action are still poorly understood. 
 
 
Thyroid development in Zebrafish 
 
In lower vertebrates such as fish, amphibia, and birds, thyroid follicular cells and C-
cells are found in separate organs. Thyroid follicular cells forms the thyroid gland and 
do not fuse with the calcitonin producing ultimobranchial bodies that can be found as 
distinct glands elsewhere in the body (Le Douarin et al. 1974; Le Lievre and Le 
Douarin 1975). 
In teleost fish, such as Danio rerio, the thyroid gland differs from that in other 
organisms. Here, follicle tissue is loosely dispersed along the ventral midline of the 
pharyngeal mesenchyme, thus, is not encapsulated by connective tissue (Raine and 
Leatherland 2000; Raine et al. 2001; Wendl et al. 2002).  
 
 
 
Schematic drawing of a zebrafish larval head of 4.5 to 6 dpf, ventral view, showing the skeleton, parts of the circulatory system and 
the thyroid. Blue, thyroid/T4 immunostaining; brown, third to sixth branchial arches; green, basibranchial cartilage; magenta, 
second branchial arch; orange, heart and ventral aorta; yellow, first branchial arch. ch, ceratohyale; h, heart; me, Meckel’s cartilage; 
pq, palatoquadrate; va, ventral aorta. 
 
 
Initial molecular studies suggest that the mechanisms of zebrafish thyroid development 
are generally comparable to that of human thyroid development (Wendl et al. 2002), 
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hence zebrafish can be useful as a model organism in further studies that aim at the 
understanding of the molecular basis of vertebrate thyroid development. 
The expression of the thyroglobulin gene in zebrafish is first observed exclusively in 
the thyroid primordium at approximately 32 hpf whereas, by an antibody against human 
thyroglobulin (TG), a first signal can be observed as a single small follicle at around 55 
hpf. During larval development, more follicles arise, aligning at the pharyngeal midline. 
This pattern of immunostaining during follicular development is identical to that 
observed using an antibody against the thyroid hormone T4. 
The analysis of zebrafish mutants that doesn’t produce TSH reveals that the absence of 
what is considered, at least in mice and humans, the most important growth factor for 
the differentiated thyroid, doesn’t affect thyroid hormone production or growth of 
follicles in zebrafish. 
The comparison of zebrafish and mouse reveals a different temporal progression of 
thyroid development in these species. The early appearance of thyroid markers before 
pharynx formation may be adaptation to fast development of zebrafish embryos. After 
4–6 days, when larvae have used up their yolk sac containing maternal thyroid 
hormone, they rely on a functional thyroid gland. At this stage, the follicles are 
proliferating as the larva and juvenile fish grow. Mouse embryos, in contrast, are 
supplied with maternal thyroid hormone up to birth, and after initial specification, 5 
days of cell proliferation occur prior to final thyroid differentiation and onset of 
function. Despite a different time scale of thyroid development in zebrafish and mice, 
nk2.1a/Nkx2.1, and pax2.1/Pax8 act presumably in the same manner during 
differentiation of the thyroid gland.  
 
 
 
The arrows indicate the onset of developmental gene expression (nk2.1, hhex, pax2.1) and differentiation markers                 
(slc5a5, ctsb and tg). 
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Comparison between thyroid development in zebrafish and mouse 
 
Three additional aspects of thyroid development in mice imply differences in the 
genetic networks that direct thyroid development compared with fish. First, the thyroid 
primordium in mice and humans bifurcates during growth. Second, in all vertebrates 
apart from most teleosts, the primordium becomes encapsuled by connective tissue. 
Third, in mammals neural crest-derived C-cells merge with the developing follicular 
cells, and indeed, these cells can form a thyroid rudiment, even in the absence of 
thyroid follicular cells (Mansouri et al. 1998). Moreover, it has been described how the 
correct development of the blood vessels and a right vasculature architecture are 
essential for the right positioning of thyroid follicles both in zebrafish (Burkhard et al. 
2006) and in mouse (Fagman et al. 2004) 
In this thesis we demonstrate that, in zebrafish, the correct positioning of thyroid 
follicles is affected by TAZ, likely because the lack of TAZ alters the development of 
the vasculature architecture. 
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Aim of the project  
 
Transcriptional regulation is a fundamental process for cellular differentiation and 
development. In an adult organism differentiated cells are characterized by the 
expression of a specific subset of genes and this expression is regulated mainly at the 
transcriptional level. A good model for studying transcriptional regulation is 
represented by thyroid follicular cells that express a very specific set of genes, called 
differentiation markers, that are thyroglobulin (TG), natrium-iodium symporter (NIS), 
thyroperoxidase (TPO) and TSH receptor (TSHr). 
Perhaps, the most important transcription factor for the differentiation and the 
development of follicular cells is Pax8 (Pasca di Magliano et al. 2000). It has also been 
described the interaction between Pax8 and another important transcriptional factor in 
thyroid development, TTF-1. Pax8 interacts with TTF-1 and these two factors are able 
to synergistically activate the transcription of the thyroglobulin gene (Di Palma et al. 
2003). Moreover, Pax8 and TTF-1 are part of an heterocomplex that has an apparent 
molecular mass greater than the sum of the two factors suggesting the presence of other 
proteins. 
In these last year different laboratories demonstrated that the Transcriptional co-
Activator with PDZ-binding motif (TAZ) is involved in several pathways: from cell 
migration to proliferation, from molecular “rheostat” in Mesenchimal Stem Cell to 
promoter of invasion in breast cancer cells. Moreover, the recently demonstrated 
physical and functional interaction between TAZ and TTF-1 in the lung raised the 
question of whether TAZ could be an important regulatory molecule also in the thyroid. 
For this reason, we decided to study whether TAZ is a co-activator of TTF-1 and Pax8 
in thyroid as well and, in parallel, we decided also to investigate in vivo the role of 
TAZ in thyroid development and differentiation.   
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RESULTS 
 
 
TAZ functions as a transcriptional coactivator for the transcription factors Pax8 
and TTF-1 
 
Protein-protein interaction is a very important event in the regulation of  gene 
expression. Transcription factors and coactivators do not act all alone rather they 
assemble in multiprotein complexes, and often they are expressed in several tissues 
while the combination of different factors is unique for a specific cell type.  
Previous studies reported that Pax8 and TTF-1 are able to form a heterocomplex 
corresponding to an apparent molecular mass greater than the sum of the two factors. 
This observation prompted us to look for the presence of other proteins participating to 
this heterocomplex and the coactivator TAZ appeared a potential interesting candidate. 
We analyzed cellular lysates from PC Cl3 thyroid cells by size exclusion 
chromatography (SEC) followed by Western blot. We detected Pax8, TTF-1 and TAZ 
in fractions corresponding to an apparent molecular mass ranging between 34–78 kDa 
thus indicating the presence in these fractions of the three monomers. More 
interestingly, the three proteins were detected also in fractions corresponding to a 
higher apparent molecular mass of about 177-440 kDa. This data strengthened our 
hypothesis of a possible interaction between TAZ and the two transcription factors in 
thyroid cells (Fig. 1A). 
In order to investigate the physical interaction between Pax8 and TAZ, and between 
TTF-1 and TAZ, recombinant GST-TAZ was purified from bacteria and used in pull 
down experiments with total protein extract prepared from PC Cl3 thyroid cells. The 
result of the pull down experiments showed that both Pax8 and TTF-1 proteins are 
specifically bound by GST-TAZ and not by the GST protein (Figs. 1B, C). To further 
investigate the possibility of a direct interaction between TAZ and the two transcription 
factors, pull down experiments were performed using the fusion protein GSTTAZ and 
bacterial Pax8 and TTF-1 proteins affinity-purified. Results of the binding reactions 
showed that GST-TAZ is indeed able to coprecipitate bacterial Pax8 and TTF-1,  
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FIG.1: (A) SEC analysis shows TTF1/PAX8/TAZ in the same fractions suggesting 
interaction between the three proteins that was confirmed by GST pull-down assay with 
GST-TAZ and protein extracts prepared from PC Cl3 cells (B, C) or full-length purified 
bacterial Pax8 (D) or TTF-1 (E). 
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whereas GST alone does not (Figs. 1D, E). These results demonstrate that the 
interaction between TAZ and Pax8 or TTF-1 already observed in pull down assays with 
total protein extracts, is indeed a direct protein-protein interaction. 
To determine whether the associations observed in vitro could take place also in vivo, 
HeLa cells were transfected with an expression vector encoding TAZ, alone or in 
combination with expression vectors encoding either 3xFLAG-Pax8 or            
3xFLAG-TTF-1.  
Anti-FLAG-agarose affinity gel was used to immunoprecipitate 3xFLAG-Pax8 or 
3xFLAG-TTF-1 proteins from total extracts prepared from HeLa cells transiently 
transfected. Subsequently, the bound proteins were subjected to Western Blot analysis 
after separation on SDS-PAGE. Western blot developed with a specific anti-TAZ 
polyclonal antibody showed the presence of TAZ coimmunoprecipitated protein in the 
presence of either 3xFLAGPax8 or 3xFLAG-TTF-1, thus proving that the association 
between TAZ and the two transcription factors occurs in vivo (Figs. 2A, B). To further 
confirm the in vivo association in the thyroid cell environment, we performed the same 
co-immunoprecipitation experiment using PC Cl3 thyroid cells stably expressing 
3xFLAG-Pax8. As shown in Fig. 2C, together with Pax8 also TTF-1 and TAZ proteins 
are immunoprecipitated. 
It was previously reported that in transient transfection assays in HeLa cells, Pax8 is 
able to activate transcription from a reporter construct named CP5-CAT in which its 
binding site is present five times in tandem upstream the CAT reporter gene. To 
investigate whether the physical interaction between Pax8 and TAZ could lead to an 
increase in Pax8 transcriptional activity, we performed transactivation assays in HeLa 
cells co-transfecting the reporter construct CP5-CAT together with the expression 
vectors encoding Pax8 and TAZ, separately or in combination. As expected, the 
transfection of Pax8 alone leads to a significant activation of the CP5-CAT promoter, 
while the transfection of TAZ alone has no effect. Interestingly, the co-expression of 
Pax8 and TAZ leads to a potent enhancement of the transcriptional activity of Pax8 on 
the CP5-CAT promoter demonstrating that the biochemical interaction between Pax8 
and TAZ results in a major functional cooperation between these two proteins         
(Fig. 3A). In parallel, we also investigated whether the physical interaction between  
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FIG.2: in vivo interaction of TAZ with both PAX8 and TTF1 revealed by 
immunoprecipitation in HeLa cells transiently transfected with 3xFLAG-PAX8 (A), 
3xFLAG-TTF-1 (B) and in PCCl3 cells stably expressing 3xFLAG-PAX8. 
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FIG.3: TAZ enhances Pax8 and TTF-1 activity on the CP5, C5 (A-B) and Tg 
promoters (C-D). 
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TTF-1 and TAZ could lead to a functional cooperation, as seen for Pax8. To this end, 
we performed transactivation experiments using the reporter construct C5-CAT in 
which the TTF-1 binding site is present five times in tandem upstream the CAT reporter 
gene. The results showed that the transfection of TTF-1 alone leads to the activation of 
the C5-CAT promoter as expected, and the co-expression of TAZ strongly potentiates 
TTF-1 transcriptional activation as it happened with Pax8 (Fig. 3B). Thus, our data 
validate that also the biochemical interaction between TTF-1 and TAZ has a major 
functional outcome. Our laboratory has previously reported that Pax8 and TTF-1 are 
able to significantly activate transcription from the thyroglobulin (Tg) promoter, and 
that the two transcription factors display a strong synergism in the transcriptional 
regulation of this promoter (Di Palma T., et al. 2003). We now asked whether TAZ 
could potentiate Pax8 and TTF-1 transcriptional activity not only on synthetic 
promoters such as the CP5-CAT and the C5-CAT ones, but also in a more 
physiological context represented by the Tg promoter. To this end, we co-transfected in 
HeLa cells the reporter construct Tg-CAT together with the expression vectors 
encoding for Pax8, TTF-1 and TAZ, separately or in combination. Also in these 
experiments, as seen for the CP5-CAT and the C5-CAT promoters, we observed a 
significant increase in the transcriptional activation of the Tg promoter by Pax8 and 
TTF-1 in the presence of TAZ (Figs. 3C, D). These results are consistent with our 
hypothesis that TAZ may act as a critical transcriptional coactivator of thyroid 
transcription factors and therefore may be involved in thyroid differentiation. 
 
 
TAZ expression profile during mouse embryonic development 
 
The morphogenesis of the thyroid, like in many endoderm-derived organs, begins with 
an event that recruits a group of cells, in an otherwise homogeneous cell layer, to the 
thyroid fate. This event is called, in developmental biology terms, “specification” or 
“determination” because, as a consequence of it, a group of cells are specified or 
determined to undertake a definite developmental program.  
The first visible change is the thickening of the endodermal epithelium in the foregut, 
which is referred to as thyroid anlage. The thyroid anlage is first identified in the mouse 
embryos at E8.5 in the ventral wall of the primitive pharynx, caudal to the region of the 
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first branchial arch. These small number of cells are univocally characterized by the 
simultaneous expression of the transcription factors Titf1/Nkx2-1, Foxe1, Pax8, and 
Hhex. This median thickening deepens, forms first a small pit (thyroid bud, E8.5–E9) 
and then an outpouching of the endoderm, which is adjacent to the distal part of the 
outflow tract of the developing heart. An influence of the developing heart on thyroid 
organogenesis has not been demonstrated, although recent data suggest that there is a 
correlation between the development of heart and thyroid. Interestingly, cardiac 
malformations represent the most frequent birth defects associated with TD (thyroid 
dysgenesis). At E9–E9.5 the endodermal cells of the thyroid anlage form the thyroid 
bud by proliferation and invasion of the surrounding mesenchyme. By E10, the thyroid 
primordium appears as a flask-like structure with a narrow neck that rapidly becomes a 
diverticulum. A small hole at the site of origin in the pharyngeal floor (the foramen 
cecum) is the remnant of the anlage, connected with the migrating thyroid primordium 
by a narrow channel (the thyroglossal duct). At E11.5 the thyroglossal duct disappears, 
and the thyroid primordium loses its connections with the floor of the pharynx and 
begins to expand laterally. Two days later the thyroid primordium reaches the trachea, 
which has extended ventrocaudally starting from the primitive laryngotracheal groove. 
By E15–E16 the thyroid lobes expand considerably, and the gland exhibits its definitive 
shape: two lobes connected by a narrow isthmus. Genes typical of this stage appear 
according to a given temporal pattern: Tg, TPO, and TSH receptor (Tshr) genes are 
expressed by E14.5 (35); sodium/iodide symporter (NIS) is detected by E16 (26). T4 is 
first detected at E16.5. 
By in situ hybridization, we analyzed several embryonic stages between 8.0 and 15.5 
days post coitum (dpc), and the adult thyroid. We show that TAZ starts to be expressed 
at 8.5 dpc in the somites and in the hindbrain (Fig. 4A) and at 9.0 dpc TAZ mRNA is 
also detectable in the forebrain (Fig. 4B). At both 9.5 (Fig. 4C) and 10.5 dpc  (Fig. 4D) 
TAZ continues to be expressed in the forebrain, hindbrain and somites; however, no 
expression could be observed in the thyroid anlage (Figs. 4E, F). On the contrary, at the 
same stages, Pax8 expression is clearly detectable in the thyroid primordium (Figs. 4 G, 
H). Later on, at 13.5 dpc, when the thyroid completes its migration and reaches its final 
destination at the base of the neck, TAZ is still not expressed in the thyroid gland (Fig. 
4I). Only at 14.5 dpc, hence rather late with respect to Pax8 (Figs. 4J, K) and TTF-
1/Titf1, TAZ starts to be expressed in the thyroid (Fig. 4L) and, like for Pax8 and 
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FIG.4: TAZ expression profile during mouse embryo development. (A–D) Whole 
mount in situ hybridization with TAZ specific probes at 8.5. (E–H) Transverse sections 
at the level of the thyroid primordium of 9.5. (I–T) In situ hybridization on sagittal 
sections at the level of the thyroid primordium of 13.5. Abbreviations: A, anterior; D, 
dorsal; fb, forebrain; hb, hindbrain; L, left; nt, neural tube; P, posterior; R, right; s, 
somites; th, thyroid; V, ventral. Scale bars represent 100 μm. 
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FIG.5: Cellular distribution of TAZ, Pax8 and TTF-1 proteins during thyroid 
development and in the adult. Immunohistochemistry with anti-TAZ (A, D and G), 
anti-Pax8 (B, E and H) and anti-TTF-1 (C, F and I) specific antibodies on parasagittal 
sections of 14.5 days post coitum (dpc) embryos (A–C), on sagittal sections of 15.5 dpc 
embryos (D–F) and in the adult (G–I). 
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TTF-1/Titf1, its expression persists at 15.5 dpc (Fig. 4O) and in the adult (Fig. 4R). 
Immunohistochemistry experiments were also performed to investigate the cellular 
distribution pattern of the TAZ protein in developing and adult mouse thyroid. As 
shown in Fig. 5, TAZ immunoreactivity was detected primarily in the nuclei of thyroid 
follicular cells both in the forming bud and in the adult gland. These results confirm the 
data observed in the cells (Figs. 5C, D) and indicate that indeed TAZ colocalizes with 
Pax8 and TTF-1 in vivo in the nucleus of thyroid follicular cells. 
 
 
Analysis of TAZ knock-out mice 
 
The TAZ locus was targeted in mouse ES cell lines with aβ-gal gene (lacZ) knock-in 
targeting vector, placing the lacZ gene into the second exon immediately downstream 
of the initiation ATG of the TAZ gene. This strategy results in a TAZ-null mutation 
with the expression ofβ-gal under the control of the endogenous transcriptional 
regulatory elements of TAZ. This mouse was generated in the laboratory of Prof. 
Walter Hunziker at the Institute of Molecular and Cell Biology (Republic of Singapore) 
We established a collaboration with him and we obtained four TAZ -/+ mice with the 
aim to spread the line and to analyze the thyroid in TAZ -/- mice. We crossed TAZ -/+ 
mice for several generations but we were not able to obtain viable TAZ -/- mice     
(Table 1). This result led us to hypothesize a possible embryonic lethality of TAZ -/- 
mice and for this reason we reasoned that it might be useful to sample embryo at E15.5. 
Unfortunately, we genotyped 77 embryos and we obtained only 4 TAZ -/- (Table 1). To 
solve this problem we are actually backcrossing TAZ -/+ mice from the sv129 
background to the c57bl6 one, hoping that changing the strain could reduce the severity 
of the phenotype.  
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Table 1: numbers (and percentages) of adult and embryos mice genotyped compared with (in white) percentage expected 
 
 
 Zebrafish (Danio rerio) - Introduction to the system - 
 
 Zebrafish (Danio rerio) comes close to being the ideal model organism for vertebrate 
development because it appears to combine the best features of all the other models. 
Like the frog, zebrafish embryos develop externally and can be viewed and 
manipulated at all stages. However, zebrafish development is more rapid than in the 
frog, the organization of the embryo is simpler and (like worms and fruit flies) the 
embryo is transparent. Like the mouse, zebrafish is amenable to genetic analysis and 
has a similar generation interval (2-3 months). However, zebrafish are smaller than 
mice and they produce more offspring in a shorter time. A female zebrafish can lay up 
to 200 eggs per week, while a mouse may produce a litter of up to 15 embryos in 21 
days. Furthermore, it is easy to induce new mutations in zebrafish and large-scale 
screens have been carried out to identify mutations causing defects in particular 
biological processes. The technology for gene transfer to zebrafish is highly advanced.  
These advantages have allowed the creation of dense genetic maps in zebrafish, which 
have been useful for the comparative mapping of human genes. There is extensive 
similarity between the zebrafish and human genomes so many human developmental 
and disease genes have counterparts in zebrafish. The zebrafish genome is 1700 million 
base pairs in length, about half the size of the human genome.  
A number of zebrafish mutants have been produced that are good models of human 
diseases, and can therefore be used to test candidate drugs. These include models of 
Alzheimer's disease, congenital heart disease, polycystic kidney disease and cancer.  
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TAZ expression in zebrafish 
 
The zebrafish thyroid primordium starts to develop at the outflow tract of the heart, 
which directly leads into the first primordial branch of pharyngeal arteries. From about 
40 hours post fertilization (hpf), the globular primordium expands along the 
anteroposterior (AP) axis into a strand of follicular tissue, thereby always remaining 
restricted to the midline. 
Of course, our first aim was to demonstrate that TAZ is expressed in the thyroid of 
zebrafish. To this purpose we performed in situ hybridization with a probe recognizing 
the entire mRNA of TAZ and we did this experiment at different stages of 
development. 
We observed that TAZ onset in the thyroid is at 48 hpf. At this stage TAZ is expressed 
also in fins, lens, notochord, otic vescicles, in the pronephric duct, in the pharyngeal 
arches and into the heart (Fig.6). 
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FIG.6: Expression pattern of TAZ at 48 hpf. In particular TAZ is expressed in the 
thyroid (B), in fins (C -cross-), otic vescicle (C -star-), lens (D), pharyngeal arches (E),           
notochord (F -star-) and in the pronephric duct (F -cross-). 
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Use of morpholino oligos to interfere with TAZ expression 
 
The impossibility to obtain TAZ -/- null mice forced us to think at different strategies for 
studying the TAZ knock-out phenotype. In recent years, morpholino antisense 
oligonucleotides have been widely used to modify gene expression, sometimes when 
the knock-out phenotype in mice is lethal and also because the generation of a knock-
out by using morpholino is cheaper and takes less time than the production of a knock-
out mouse by homologous recombination. 
Microinjection or electroporation of morpholino oligos into the embryos of frogs, 
zebrafish, chicks, sea urchins and other organisms successfully and specifically shuts 
down the expression of targeted genes, making morpholinos a useful tool for 
developmental biologists. 
Morpholino oligos are short chains of about 25 morpholino subunits. Each subunit is 
comprised of a nucleic acid base, a morpholine ring and a non-ionic 
phosphorodiamidate intersubunit linkage. Morpholinos do not degrade their RNA 
targets, but instead act via an RNAse H-independent steric blocking mechanism. With 
their requirement for greater complementarity with their target RNAs, morpholinos are 
free of the widespread off-target expression modulation typical of knockdowns which 
rely on RISC or RNase-H activity. Depending on the oligo sequence selected, 
morpholinos either can block translation initiation in the cytosol (by targeting the 5' 
UTR through the first 25 bases of coding sequence), can modify pre-mRNA splicing in 
the nucleus (by targeting splice junctions or splice regulatory sites). 
For our experiments we designed oligo morpholino against the ATG of the TAZ gene. 
We microinjected 1ng of morpholino in zebrafish embryos at 1 to 2 cells stage. Until 40 
hpf TAZ morphants appear normal and they are indistinguishable if compared to  
control embryos not microinjected. From 40 hpf TAZ morphants develop  heart edema, 
ventral curvature and their head is smaller and abnormally shaped. (Fig.7) 
 
 
The thyroid gland in TAZ morphants is fully differentiated 
 
Four transcription factors have been shown to play crucial roles in the development of 
thyroid follicular cell precursors in mammals. TTF-1/Nkx2.1, Foxe1, Hhex and Pax8  
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FIG.7: TAZ morphants are characterized by heart edema (B), smaller and abnormally 
shaped head (B), ventral curvature (D) and defect in pronephric duct (D) 
 
 
 
are expressed during thyroid development in mice, and the corresponding knock-out 
phenotypes show loss or reduction in size of the thyroid primordium soon after initial 
steps of thyroid development (De Felice et al., 1998; Kimura et al., 1996; Mansouri et 
al., 1998; Martinez Barbera et al., 2000). In zebrafish, nk2.1a, hhex, and pax8 are also 
expressed in the developing thyroid (Rohr and Concha, 2000; Wendl et al., 2002). 
Additionally, pax2.1 is expressed in these cells, and its loss-of-function phenotype in 
noi -/- mutant embryos shows that pax2.1 is required for the development of thyroid 
follicles (Wendl et al., 2002). pax8 appears to be downstream of pax2.1 in zebrafish 
thyroid development, and it is rather pax2.1 that has a role comparable to Pax8 in 
mammalian thyroid development. 
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FIG.8: Expression levels of TTF1, PAX2.1 and PAX8 are the same between TAZ 
morphants (on the left) and wild type (on the right) 
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Based our data obtained in thyroid cells, we knew that TAZ behaves as a transcriptional 
coactivator for both Pax8 and TTF-1, hence we wondered whether the lack of TAZ 
could affect the development of the thyroid gland. To test this hypothesis, we 
performed in situ hybridization with probes recognizing the mRNAs of TTF-1, Pax8 
and Pax2.1 that are the fundamental genes for the correct development of the thyroid 
gland in zebrafish (Elsalini et al. 2003). At 48 hpf we did not observe any difference in 
the expression and localization of the three transcription factors, between TAZ 
morphants and wild type suggesting that, at 48 hpf, thyroid development in TAZ 
morphants is not affected (Fig.8). 
We also know that, in thyroid cells, TAZ is able to enhance Pax8 and TTF-1 synergistic 
activity on the Tg promoter and that thyroglobulin production is essential for the 
synthesis of  the thyroid hormone T4. Starting from these data we wondered whether 
the lack of TAZ could lead to a downregulation of Tg expression and, as a 
consequence, could affect the synthesis of T4. By immunohistochemistry with specific 
antibodies against Tg and T4 we analyzed the expression of these two proteins in TAZ 
morphants. At 5 dpf (days post fertilization) the levels of the expression of both Tg and 
T4 are the same in the wild type and in TAZ morphant embryos (Fig.9). 
At this stage, whereas differentiation seems to be not affected, we found that thyroid 
follicles in TAZ morphants are not disposed along AP axis, like in wild-type, but they  
appear larger owing to a lateral expansion. Moreover the number of thyroid follicles is 
decreased: ~ 4-5 in wild type and ~ 2-3 in TAZ morphants. 
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FIG.9: TAZ morphants show thyroid abnormalities in the disposition and in the 
number of thyroid follicles. 
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Impaired blood vessel formation in zebrafish lacking TAZ 
 
The thyroid gland in vertebrates develops close to vascular structures. In different 
studies it has been described that in zebrafish and mouse embryos, with altered vessel 
architecture, defects in pharyngeal/cervical vessels coincide with abnormal thyroid 
development in both species (Fagman et al. 2005; Alt et al. 2006). 
In zebrafish and mouse development, two morphogenetic phases are distinguishable in 
thyroid relocalisation. After induction and evagination, the thyroid primordium adopts a 
position close to the cardiac outflow tract in zebrafish and to the aortic sac in mice, 
respectively. Consequently, follicles cluster at a default position around the cardiac 
outflow tract in the deficient zebrafish larvae (Vascular Endothelial Growth Factor 
morphants), and the primordium initially relocalises correctly in the midline of E11.5 
Dsh/Dsh mice (Sonic Hedgehog null mice). In a second phase of relocalisation that is 
dependent on ventral aorta or carotid artery development, the thyroid then adopts its 
species-specific position further cranially. In the complex and derived circulation of 
mice, the aortic sac is in part homologous to the cardiac outflow tract and probably also 
to the ventral aorta in zebrafish. Thus, the first phase of thyroid relocalisation from the 
pharyngeal epithelium to cardiac structures appears to be evolutionary conserved, 
whereas the second phase seems to be adapted to the presence of different cranial 
vessels. These data suggest that the dependence of thyroid morphogenesis on the 
development of adjacent arteries is a conserved mechanism that might have evolved to 
ensure efficient hormone release into circulation. 
The failure of positioning of thyroid follicles along AP axis in TAZ morphants let us to 
hypothesize that an impairment in blood vessels formation might be the explanation of 
the TAZ morphants phenotype. To verify our hypothesis we microinjected 1ng of TAZ 
morpholino in a transgenic line, TG(KDR-like:gfp), in which the Green Fluorescent 
Protein (GFP) expression is controlled by the kdr-like promoter (Vascular Endothelial 
Growth Factor receptor) hence by following GFP expression we can monitor the entire 
vasculature architecture of the embryo. 
Immunohistochemistry with the antibody against T4 revealed that, at 4 dpf, vascular 
architecture in the head of TAZ morphants is completely perturbed if compared with 
wild type, and that the positioning of the thyroid follicles is affected because the ventral 
aorta, in the head of the morphants, is absent (Fig.10). 
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FIG.10: TAZ morphants (B) show completely altered blood vessel architecture in the 
head if compared with wild type (A); red: thyroid follicles (T4); green: blood vessels 
(KDR-likebGFP).
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The zebrafish thyroid primordium starts to develop at the outflow tract of the heart, 
subsequently, at about 70 hpf, thyroid follicles start to migrate along the ventral aorta. 
Phospholipase C-γ 1 (PLC-γ 1), a well known effector of receptor tyrosine kinase 
signaling, is involved in the regulation of primitive hematopoiesis in zebrafish embryos 
(Ma et al. 2007). PLC-γ 1 loss of function mutants (PLC-γy10) are characterized by a 
specific defect in the formation of arteries, whereas the development of veins appears 
unaffected (Lawson et al. 2003). 
In the transgenic line  TG (fli1:gfp)y10 , GFP expression is controlled by the promoter of 
the endothelial marker fli1. Hence, by following the expression of fli1 we are able to 
observe both lymphatic and blood vessels and, into the head, also the precursor of 
chondrocytes and neural crest cells. Immunostaining with the antibody against T4 
revealed that thyroid follicles in PLC-γy10 at 4 dpf are still in close contact with the 
outflow tract of the heart whereas into wild type thyroid follicles are normally 
positioned along ventral aorta (Figs. 11A, C). 
Mitana et al. (AJRCCM 2009) described a lung phenotype of TAZ -/- mice. These mice 
showed abnormal alveolarization during lung development, which caused in adult mice 
airspace enlargement mimicking emphysema. They also measured the expression of 
various marker genes and they found that expression of vascular endothelial growth 
factor receptor - 2 (VEGFR-2, KDR), in TAZ null mice, was markedly decreased. 
Strikingly we found the PPXY motif in the KDR-like sequence, in zebrafish, hence we 
wondered if impairment in blood vessel development, in TAZ morphants, might be due 
to a downregulation of KDR-like expression.  
Zebrafish KDR-like loss of function mutant (KDR-like t20257) develop a normal vascular 
architecture up to 1,5 dpf. After this stage they show blood vessels malformations, in 
particular none of the central arteries in the head could be detected in 
microangiographies up to 4 dpf (Habeck et al. 2002). 
We performed immunohistochemistry with the antibody against T4 and we observed 
that TG (fli1:gfp)t20257 at 4 dpf show a phenotype very similar to TAZ morphants. 
KDR-like t20257 also lacking ventral aorta into the head and the right positioning of 
thyroid follicles is affected. Moreover the number of thyroid follicles is decreased as 
well (Figs. 11A, B). 
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FIG.11: Correlation between defect in blood vessels development and thyroid 
abnormalities in KDR-like null mutation (B) and in PLC-γ null mutation (C) lines. Red: 
thyroid follicles (T4)
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Lack of skeletal ossification in TAZ-depleted zebrafish 
 
Apart the already mentioned role of TAZ in stimulating differentiation of mesenchimal 
stem cells (MSCs) in osteoblasts,  it has been reported that, in isolated and purified 
MSCs from bone marrow of multiple myeloma (MM) patients, TAZ expression is 
correlated with the osteogenic potential of MSCs. In particular, TAZ mRNA expression 
and protein levels in MSCs were measured and they were both significantly decreased 
in the MM group compared to the normal group. Takes on the whole these data let us to 
think that might be interesting to investigate the osteogenic phenotype of TAZ 
morphants and to observe if they show some abnormalities in bones or cartilages.  
Supporting this hypothesis there is the fact that TAZ morphants are smaller than wild 
type, they develop ventral curvature and their head appear smaller and abnormally 
shaped. 
By Alcian Blue/Alizarin Red staining we are able to recognize cartilages and bones 
respectively. As we hypothesized in TAZ morphants at 6 dpf both ossified than 
cartilage tissues are absent. (Fig.12) 
 
FIG.12: Alizarin Red/Alcian Blue staining show lacking of both ossified and cartilage 
tissue in TAZ morphant 
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DISCUSSION 
 
 
Transcriptional regulation is the most important way of modulating gene expression 
both in eukaryotes and in bacteria because it contributes to define the proteins 
expressed by a cell and, as a consequence, the functions characteristic of a cell. 
Specifically, this mechanism of regulation is more relevant in pluricellular organism 
where it allows a gene to be expressed in the right cell and at the right moment during 
development and differentiation. 
A pivotal role in transcriptional regulation is hold by transcription factors. We can 
define transcription factor any protein other than RNA Polymerase that is required for 
transcription. Transcription factors however often don’t act alone but they are part of 
protein heterocomplexes in which they interact with different transcription factors, with 
accessories proteins and with transcriptional co-activators/repressors.  
TAZ (Transcriptional co-Activator with PDZ binding motif) is a transcriptional 
coactivator that, in these last years, has been described to interact with, and to regulate, 
several transcription factors (Murakami, et al. 2005; Murakami, et al. 2006; Mahoney, 
et al. 2005; Hong, et al. 2005; Park, et al. 2004). Moreover, it was suggested also a role 
of TAZ in the migration, invasion, and tumorigenesis of breast cancer cells and it has 
been demonstrated that  TAZ is overexpressed in a significant fraction of breast cancers 
(Siew Wee Chan, et al. 2008). TAZ is also a component of Hippo pathway in which the 
activation a TAZ leads to migration and cell proliferation (Zhang, et al. 2009). 
During my Ph.D, I have been interested in studying the thyroid gland. In particular, our 
attention has been focused on thyroid development and differentiation. Functional unit 
of the thyroid gland is the thyroid follicular cell that is characterized by the expression 
of specific proteins called, for this reason, differentiation markers; these are 
thyroglobulin (Tg), thyroperoxidase (TPO) and natrium-iodium symporter (NIS). For 
the expression of these differentiation markers it is necessary that the thyroid follicular 
cell expresses three tissue specific transcription factors: TTF-1, Pax8 and Foxe1 
(Damante G, et al. 2001). 
Previous studies reported that Pax8 and TTF-1 are able to form a heterocomplex, hence 
we wondered whether TAZ might be part of this complex. By size exclusion 
chromatography (SEC) on cellular lysates from PC Cl3 thyroid cells we observed the 
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presence of TAZ, TTF-1 and Pax8 in the same fractions corresponding to a molecular 
mass of about 177-440 kDa. Starting from this data we performed experiments with the 
aim to investigate the physical interaction between TAZ and Pax8/TTF-1. 
To interact with a transcription factor TAZ needs to find the L/PPXY motif in the 
activation domain of its partner (Kanai, et al. 2000). We identified the LPGY motif in 
the Pax8 sequence and LPPY motif in TTF-1. Indeed, we demonstrated the interaction 
in vitro and in vivo between TAZ and both Pax8 and TTF-1. Since it is well established 
that TAZ might regulate transcription through the WW domain-PPXY motif interaction 
(Kanai, et al. 2000), we investigated whether in our case this interaction could regulate 
the transcriptional activity of either Pax8 and/or TTF-1 and we demonstrated that TAZ 
is a potent transcriptional coactivator also for these two thyroid specific transcription 
factors. We demonstrated also that TAZ significant increases the synergistically 
activation of Pax8 and TTF-1 on the Tg promoter. 
Looking at the expression pattern of TAZ in the mouse, we observed that only at 14.5 
dpc, hence rather late with respect to Pax8 and TTF-1, TAZ starts to be expressed in the 
thyroid gland. Intriguingly, Pax8 and TTF-1 onset can be observed at 8.5 dpc while Tg 
expression, that is regulated by these two factors, starts only at 14.5 dpc. Hence, we 
always wondered what is missing between 8.5 dpc and 14.5 dpc that could explain the 
time-lag between the expression of Pax8 and TTF-1, and Tg. For this reason we thought 
it was really interesting that a gene that is able to increase the synergistic activation of 
Pax8 and TTF-1 on the Tg promoter starts to be expressed in the nucleus of thyroid 
follicles at the same time as Tg. 
Taken altogether these data suggested us that TAZ might have an important role in 
thyroid development and differentiation and for this reason we thought that it could be 
interesting to investigate the role of TAZ in vivo. 
We obtained TAZ -/- mice, as a collaboration, with the aim of studying the development 
and the differentiation of the thyroid gland in mice lacking TAZ. 
Unfortunately, we genotyped 258 mice but we were not able to obtain TAZ null mice. 
We thought at a possible embryonic lethality and for this reason we sampled embryos at 
E15.5. However, also in this case we obtained only four TAZ knock-out mice 
suggesting that embryonic lethality happens earlier than E15.5. One way to try to obtain 
TAZ null mice is to backcross the line from sv129 background to c57bl6 one. At this 
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time we are doing this crosses and we hope that in a different strain TAZ -/- phenotype 
could be less severe and we will be able to obtain knock-out mice. 
In parallel, while performing the backcross, we decided to study the role of TAZ in the 
development and differentiation of thyroid cells in zebrafish (Danio rerio). We made 
this choice for several reasons. Apart from the well known advantages of the zebrafish 
model, we thought that studying TAZ in zebrafish could allow us to know, in a relative 
short period of time, if the lack of TAZ in vivo affects in some way thyroid 
differentiation and development. 
Thyroid morphology in zebrafish is peculiar and very different from that in human. 
Nevertheless, some papers demonstrated that the mechanisms of thyroid development 
in zebrafish are generally comparable to human thyroid development (Elsalini, et al. 
2003). 
First of all we demonstrated, by in situ hybridization, that TAZ is expressed in the 
thyroid of zebrafish and that its expression starts at 48 hpf. Subsequently, we used a 
specific morpholino oligonucleotide to interfere with TAZ expression. 
Despite the data obtained  in thyroid cells, we observed that the thyroid in TAZ 
morphants is fully differentiated and the expressions of Tg and T4 is not affected. 
Strikingly, immunohistochemistry with antibodies against Tg and T4 revealed that in 
TAZ morphants the position of the thyroid follicles was completely different if 
compared to wild type. In fact, in TAZ morphants the follicles fail to align along the AP 
axis and it seems like the follicles fail to migrate towards their right position. 
It has been reported that, both in mouse and in zebrafish models with an abnormal 
vascular architecture, migration of the thyroid gland strictly depends on the right 
development of ventral aorta, in zebrafish, or of carotids, in mouse (Alt, et al. 2006; 
Fagman, et al. 2004). For this reason we wondered whether in TAZ morphants the 
development of the ventral aorta might be affected and, as a consequence, the thyroid 
follicles cannot migrate normally. 
Microinjection of TAZ morpholino in TG(KDR-like:gfp) revealed that, as we expected, 
the vascular architecture in the head of TAZ morphants was completely different from 
that of wild type. Moreover TAZ morphants lack the ventral aorta and the thyroid 
follicles are still attached to the blood vessel but closer to the heart because they cannot 
migrate. We further demonstrated that ventral aorta has a role in thyroid follicles 
migration by looking at thyroid follicles in PLC-γ loss of function mutants  in which the 
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ventral aorta doesn’t develop. We observed that, also in this case, the thyroid follicles 
are still close to the heart attached to the outflow tract. 
This is an additional evidence that, with respect to thyroid follicles, migration and 
differentiation are two independent processes and that, in our case, migration is affected 
whereas differentiation isn’t. 
By observing blood vessels phenotype of TAZ morphants our idea is that TAZ could 
interact with some factor important for blood vessels formation and that, in zebrafish 
lacking TAZ, this factor is downregulated and for this reason the development of the 
vessel architecture is affected. The downregulation of KDR in the lung of TAZ-/- mouse 
and the presence of PPXY motif in KDR-like sequence, let us think that in TAZ 
morphant KDR might be downregulated. Supporting our hypothesis also a KDR-like 
loss of function mutant lacks the ventral aorta, like in TAZ morphants, and, moreover, it 
showed a decreased number of thyroid follicles that don’t migrate properly. Of course, 
we need further data to confirm that the vascular phenotype of TAZ morphant is due to 
a downregulation of KDR-like, but this is an encouraging data indicating that our 
hypothesis might be true. 
Another well outlined role of TAZ is in the differentiation of mesenchimal stem cell in 
osteoblasts (Jeong-Ho Hong, et al 2005). Some data demonstrate a downregulation of 
TAZ in pathologies in which the osteogenic pathway is affected (Bingzong Li, et al. 
2007). In fact, TAZ is also able to interact and to activate, under the control of Bmp4, 
Runx2 that has a pivotal role in osteoblasts differentiation (Jeong-Ho Hong, et al 2005). 
In our experiments, TAZ morphants are characterized by smaller head and ventral 
curvature, hence we thought that osteogenesis and chondrogenesis could be affected in 
zebrafish lacking TAZ. As we hypothesized, TAZ morphants at 6 dpf totally miss both 
bones and cartilages. 
Our data obtained in zebrafish are extremely consistent with those obtained in cells and 
observed in some pathologies whereas the analysis of TAZ -/- mice shows some 
inconsistencies. In fact, TAZ null mouse is characterized only by kidney and lung 
phenotype whereas bones develop normally and there are no data regarding blood 
vessels and thyroid development. One of the characteristic of zebrafish is that they can 
live up to the first week of development without a functional vasculature or heart beat, 
allowing a detailed analysis even in animals with severe cardiovascular defects; by 
contrast, avian and mammalian embryos die rapidly in the absence of a functional 
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cardiovascular system. Hence impairment in blood vessels development, that we 
observe in TAZ morphants, might be the reason of early embryonic lethality that we 
observed in TAZ null mouse. 
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MATERIALS AND METHODS 
 
 
Plasmid constructs 
 
The plasmids used have been previously described and were as follows: Tg-CAT,     
C5-CAT and CP5-CAT, CMV5-Pax8 , 3xFLAG-Pax8, CMV-TTF-1, Δ14 and Δ3, 
GST-TAZ and CMV-TAZ. The GST-N-TAZ, GST-W-TAZ and GST-C-TAZ fusion 
proteins were generated by PCR amplification of the different portions of TAZ coding 
region and subsequent subcloning in the EcoRI-XhoI sites of the pGEX-4T3 vector. 
The mutants TTF-1AAPA and Pax8AAGA were constructed using the Quick Change 
XL Site-Directed Mutagenesis kit (Stratagene) using as template the CMVTTF1 and 
CMV5-Pax8 vectors, respectively. Mutant Δ349 was generated by PCR amplification 
of a portion of Pax8 cDNA (corresponding to 349 amino acids) and subsequent 
subcloning in the HindIII-XbaI sites of pCMV5. 
 
 
Cell culture, transfections and reporter assays 
 
PC Cl3 and FRTL-5 cells (Berlingieri et al. 1988; Fusco et al. 1987) were grown in 
Coon's modified F-12 medium (Euroclone) supplemented with 5% calf serum and a 
six-hormone mixture (6 H) as described by Ambesi-Impiombato and Coon (Ambesi-
Impiombato et al. 1979). 
HeLa cells were grown in Dulbecco's modified Eagle's medium (Euroclone) 
supplemented with 10% fetal calf serum (Hyclone). For transient transfection 
experiments, cells were plated at 3×105 cells/60-mm tissue culture dish 5 to 8 h prior to 
transfection. Transfections were carried out with the FuGENE6 reagent (Roche 
Diagnostics) according to the manufacturer's directions. The DNA/FuGENE ratio was 
1:2 in all the experiments. The plasmid CMVLUC was used as internal control and the 
total amount of transfected DNA was kept constant with an empty expression vector in 
all the transfection assays. All the data were normalized to the ratio of CAT/LUC 
activity and the Tg-CAT, C5-CAT and CP5-CAT reporters value was set to 1. Cells 
extracts were prepared 48 h after transfection to determine either the levels of the CAT 
???
?
protein with a CAT enzyme-linked immunosorbent assay kit (Roche Diagnostics) or the 
LUC activity by a Luciferase assay as previously described (de Wet 1987). 
Transfection experiments were done in duplicate and repeated at least three times. CAT 
activity values on the graph are the means of all experiments (+/–) SD. Statistical 
analysis has been performed by means of an unpaired two-tailed Student's t test to 
obtain the P value associated with the observed fold of activation differences. 
 
 
Protein extracts and immunoblotting 
 
For Western blot and reporter assays, cellswerewashed twice with ice-cold phosphate-
buffered saline (PBS) and lysed in a buffer containing 10 mM Hepes pH 7.9, 400 mM 
NaCl, 0.1 mM EGTA pH 7.8, 5% glycerol, 1 mM dithiothreitol (DTT), 1 mM 
phenylmetilsulfonil fluoride (PMSF). The same buffer was used for the lysis of the 
thyroid tissue. For GST-pull down assays PC Cl3 cells were washed twice with PBS 
and lysed in WCE buffer containing 50 mM Tris pH 7.5, 100 mM NaCl, 0.1% Triton 
X100, 10% glycerol, 1 mM DTT, 1 mM PMSF and protease inhibitors (Sigma). For 
immunoprecipitation experiments cells were washed twice with PBS and lysed in EBC 
buffer containing 50 mM Tris pH 7.5, 120 mM NaCl, 0.5% Nonidet P-40, 10% 
glycerol, 1 mM DTT, 1 mM PMSF and protease inhibitors (Sigma). 
Cell fractionation into cytoplasmic and nuclear fraction was prepared by a variation of 
the standard protocol of Dignam (Dignam et al. 1983), as previously described 
(D’Andrea et al. 2006) 
The protein concentration was determined using the Bio-Rad protein assay (Bio-Rad 
Laboratories, Inc., Hercules, CA). For Western blot analysis, proteins were separated 
by SDS-10% PAGE, gels were blotted onto Immobilon P (Millipore, Bredford, MA, 
USA) for 2 h and the membranes were blocked in 5% nonfat dry milk in Tris-buffered 
saline for 2 h or overnight before the addition of the antibody for 1 h. The primary 
antibodies used were anti-TAZ (kindly provided by T. Benjamin), anti-Pax8 and 
anti-TTF-1 (kindly provided by R. Di Lauro), anti-Sp1 (Santa Cruz, CA), anti-tubulin 
(Santa Cruz, CA), anti-FLAG (Sigma), anti-GST (kindly provided by P. Di Fiore). The 
filters were washed three times in Tris-buffered saline plus 0.5% Tween 20 before the 
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addition of horseradish peroxidase-conjugated secondary antibodies for 45 min. 
Horseradish peroxidase was detected with ECL (GE Healthcare) 
 
 
Pull down assay and coimmunoprecipitation 
 
GST-TAZ protein was purified from BL21 (DE) LysS bacterial cells as previously 
described [20]. For the synthesis of bacterial TTF-1, E. Coli cells were transformed 
with pQE12-TTF-1, an expression vector encoding for TTF-1 fused to a His6 tag at the 
C terminus. The expression and the purification of TTF-1 protein were performed as 
previously described (Aurisicchio et al 1998). The purification of Pax8 protein was 
performed using the same protocol described for TTF-1. For pull down assays, GST or 
GST-TAZ bound to glutathione beads were incubated with 3 mg of total protein extract 
prepared from PC Cl3 cells or 10 ng of bacterial purified proteins. Binding reactions 
were carried out for 90 min at 4°C on a rotating wheel. After extensive washing with 
WCE buffer, bound proteins were detected by Western blot. To analyze the interaction 
of TAZ with Pax8 and TTF-1, a construct expressing TAZ was transfected into HeLa 
cells along with vectors containing FLAG-tagged TTF-1 and Pax8. About 48 h after 
transfection, cells were washed twice with PBS and lysed in EBC buffer. 5 mg of total 
protein extract was purified on anti-FLAG agarose affinity gel (Sigma) overnight at 
4°C on a rotating wheel. Bound proteins were eluted by resuspending the beads directly 
in 2×SDS-PAGE sample buffer and heating at 95°C for 5 min. before loading on the 
gel. The same conditions were used when the coimmunoprecipitation experiment was 
performed using PC Cl3 cells. 
 
 
Size Exclusion Chromatography (SEC) 
 
For SEC analysis 2 mg of total extract was loaded on a Superose 6 10/300 GL (GE 
Healthcare) gel filtration column equilibrated in sodium phosphate buffer, pH 7.2, 
containing 120 mM NaCl. For Western blot analysis, the indicated fractions were 
subjected to trichloroacetic acid precipitation before loading on SDS-PAGE 
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In situ hybridization on mice 
 
For embryo collection, CD1 mice were crossed. Noon of the day on which the vaginal 
plug was detected was considered as 0.5 dpc in the timing of the embryo collection. 
Timed pregnant females were killed by cervical dislocation and embryos were dissected 
from decidual tissue in cold PBS and fixed overnight in 4% paraformaldehyde in PBS 
at 4°C. For RNA whole mount in situ hybridization (WISH), embryos have 
beenwashed in PBT (0.1% Tween 20 in PBS), dehydrated through ascending methanol 
and stored at-20°C. WISH experiments were performed as previously described 
(Liguori et al. 2003). The embryos were then photographed using a Leica DFC300 F 
digital camera. Subsequently, some embryos were embedded in 7.5% gelatin, frozen, 
sectioned using a MICROM HM 560 cryostat, and then examined and photographed 
using a Leica DM6000 B microscope and a Leica DFC480 digital camera. For RNA in 
situ hybridization on sections, embryos and adult thyroids have been washed in PBT 
(0.1% Tween 20 in PBS), dehydrated through ascending ethanol, washed in Toluene 
and Toluene-Paraffin 1:1, included in paraffin and then sectioned using a 2030 
Reichert-Jung microtome. RNA in situ hybridization on sections was performed as 
previously described (Rugarli et al. 1993). Embryo sections were then photographed 
using a Leica DC300 digital camera. The following probes were used: full-length 
mPax8, full-length mTAZ, TAZ-Pr1, part of TAZ cDNA amplified with the mouse 
TAZ-specific primers 5′-AGGATCCAGATGGAGAGAGAGAG-3′ and 5′-
AGTAGTGATTACAGCCAGG-3′ and a Tg fragment (Lazzaro et al. 1991) 
 
 
Immunohistochemistry on mice 
 
Embryos and adult thyroids were dissected in cold PBS and fixed overnight in 4% 
paraformaldehyde in PBS at 4°C. Samples were washed in PBT (0.1% Tween 20 in 
PBS), dehydrated through ascending ethanol, washed in Toluen and Toluen-Paraffin 
1:1, included in paraffin and then sectioned using a 2030 Reichert-Jung microtome. 
Sections were dewaxed by standard techniques and heat treated (microwave oven) in 
citrate buffer 0.01 M ph 6.0 to retrieve the antigen sites. To quench endogenous 
peroxidases, the sections were treated in 0.3 % hydrogen peroxide in methanol for 30 
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minutes at room temperature. The sections were incubated in blocking solution (1% 
BSA, 10% Normal Goat Serum, in PBS1X) for 1 hour at room temperature and then 
with the primary antibodies in the same solution overnight at 4°C. Sections were 
washed twice in PBT for 5 minutes and then incubated with the goat anti-rabbit 
secondary antibody (Dako, 1:400 dilution) for 1 hour at room temperature. Staining 
procedures and chromogenic reactions were carried out according to the Vectastain 
ABC kit protocol (Vector Laboratories). After diaminobenzidine (Sigma) reaction, the 
sections were counterstained with eosin solution (Sigma) for 30 seconds. The following 
primary antibodies were used: anti-Taz (Santa Cruz Biotechnology; sc-48805, 1:25 
dilution), anti-Pax8 (kindly provided by R. Di Lauro, 1:1000 dilution) and anti-TTF-1 
(kindly provided by R. Di Lauro, 1:1500 dilution). 
 
 
Zebrafish 
 
Zebrafish work was carried out according to standard procedures (Westerfield, 2000). 
Staging in hours post fertilisation (hpf) or days post fertilisation (dpf) refers to 
development at 28.5°C. The following mutant fish lines were used: plcg y10 (Lawson et 
al. 2003), kdr-like t20257 (Habeck et al. 2002). 
 
 
Embryonic manipulation 
 
Antisense morpholino oligonucleotides directed against the zebrafish TAZ translation 
initiation codon (zTAZ MO: 5’-CTGGAGAGGATTACCGCTCATGGTC-3’) and a 
standard control oligomer (Con MO) were purchased from GeneTools LLC (Philomath, 
OR). Zebrafish embryos in the 1- to 2-cell stage were injected with 1 ng of 
oligonucleotides in 1 × Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 
0.6 mM Ca(NO3)2, 5 mM Hepes pH 7.6). We always injected morpholinos into one-
cell-stage embryos. All phenotypes described were consistently found in over 70% of 
morphants, with the rest showing milder defects or wild-type appearance. 
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Immunohistochemistry on zebrafish embryos 
 
For whole-mount antibody staining, larvae from 4 to 6 dpf were fixed in 
paraformaldehyde (PFA) at 4°C overnight or for 1 h at room temperature, washed in 
phosphate-buffered saline containing 0.3% Tween (PBT), then washed and stored in 
methanol at - 20°C. For bleaching, and to block endogenous peroxidases, embryos were 
incubated in 3 ml 10% H2O2 in methanol overnight at room temperature. 
Larvae were washed in PBT, blocked in normal goat serum for 2 h, incubated with a 
polyclonal antibody (1:4000 rabbit anti-thyroxine BSA serum, ICN Biochemicals) that 
detects thyroid hormone at its location of production in thyroid follicles (Raine et al., 
2001) O/N at 4°C, then washed in PBT for 3 h. Incubation with a biotinylated 
secondary antibody was for 2 h, washing in PBT for 3 h. Incubation with the ABC kit 
(Vectastain) was for 2 h according to the instructions of the manufacturers. Larvae were 
washed again in PBT for 3 h, then once in PBS, and incubated in DAB (0.2 mg/ml 
PBS) for 30 min. To stain, 1 µl of a 0.3% aqueous H2O2 solution was added under 
observation by using a dissection scope. All procedures were carried out at room 
temperature, washing steps can be extended at 4°C. 
For detailed analysis, larvae were postfixed in PFA for 15 min at room temperature, 
washed in PBT, and gradually transferred to 70% glycerol.  
For analysis at confocal microscope whole-mount embryos were embedded in 0,5% 
agarose and examined and photographed using Leica SPE microscope. Images were 
processed using Leica LASAF lite software. 
 
 
Labelling of the probe 
?
0.5-1 μg of the linear plasmidic DNA was used in the in vitro transcription reaction for 
the synthesis of antisense RNA labelled with DIG. For synthesis of in situ probe, a 20 
μl reaction was set up containing 2 μl 10x transcription buffer, 2 μl DIG-labelling mix, 
0.5 μl RNasin, 1 μl RNA polymerase and RNAse free H2O. Transcription mix was 
incubated at 37°C for 2-4 h. The RNA was then washed in distilled H2O by using 
Millipore filter tubes. 
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In situ hybridization on zebrafish embryos 
 
Embryos up to 48 hpf were fixed in 4% PFA ON and stored in 100% methanol            
at -20°C. After 12 h, they were washed twice with PBT, digested with 10 µg/ml 
proteinase-K in PBT for several minutes depending on the stage, washed further and 
fixed again in 4% PFA for 20 min. After additional washes, the embryos were 
prehybridized for 2-4 h at 62°C and then digoxigenin (DIG)-labelled RNA probe was 
added to the final concentration of approximately 50 ng/ml and hybridized ON at 62°C. 
The embryos were then submitted to several washing treatments such as: at 62°C in 
Hyb-/2XSSC (75:25) for 15 min; at 62°C in Hyb-/2XSSC (50:50) for 15 min and at 
62°C in Hyb-/2XSSC (25:75) for 15 min. To prevent the nonspecific staining, they 
were then kept at least for 2 h at room temperature (RT) in blocking reagent (Roche) 
and then incubated for 2 h with anti-DIG-AP antibody (Roche) (1:6000 dilution in 
blocking reagent), followed by washing in PBT ON. The following day, the embryos 
were rinsed with staining buffer (X-pho buffer) (0.1 M Tris pH 9.5, 0.05 M MgCl2,   
0.1 M NaCl, 0.1% Tween 20) and stained with BM purple AP substrate, precipitating 
(Roche). The staining reaction was stopped by the addition of PBT, followed by the 
fixation in 4% PFA. The stained embryos were then washed in PBT, gradually 
transferred to 90% glycerol and studied for detailed analysis. Whole-mount embryos 
were examined with an AXIOPLAN 2 microscope equipped with Axiocam digital 
camera (Zeiss). Images were processed using Axion Vision software. 
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